Highlights Mankind Pharma Limited

Equities

MANKIND

INE634S01028

Market Closed - NSE India S.E. Other stock markets 07:40:31 2024-07-09 am EDT			5-day change	1st Jan Change
2,102 ^INR	+1.95%		-1.25%	+6.05%

Jul. 09	Mankind Pharma Reportedly to See Stake Sale Worth INR 7,630 Million through Block Deal	CI
Jul. 05	Bain-backed Emcure Pharma's $234 million India IPO draws $11 billion in bids	RE

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Mankind Pharma Reportedly to See Stake Sale Worth INR 7,630 Million through Block Deal	Jul. 09	CI
Bain-backed Emcure Pharma's $234 million India IPO draws $11 billion in bids	Jul. 05	RE
Advent International Receives 6-7 Bids for Bharat Serums	May. 30	CI
Mankind Pharma's Consolidated Profit Jumps in Fiscal Q4	May. 16	MT
India's Mankind Pharma's Q4 profit jumps on strength in chronic drugs segment	May. 15	RE
Mankind Pharma Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	May. 15	CI
Mankind Pharma Reportedly in Fray to Acquire Advent's Stake in Bharat Serums	May. 14	CI
KKR, Novo Nordisk, Others Reportedly Bid for Healthium Buy	May. 02	CI
Mankind Pharma to Sell its Over the Counter Business on Slump Sale Basis	Apr. 03	CI
Mankind Pharma to Sell OTC Business to Wholly-Owned Subsidiary	Apr. 03	MT
Mankind Pharma to Form New Subsidiary for Consumer Healthcare Products	Apr. 02	MT
Mankind Pharma Limited Announces Incorporation of Wholly Owned Subsidiary Mankind Consumer Products Private Limited	Apr. 02	CI
Mankind Reportedly Joins Race for Healthium Medtech	Mar. 28	CI
AstraZeneca, Mankind Pharma Tie Up for Exclusive Distribution of Asthma Drug Symbicort in India	Mar. 11	MT
Astrazeneca Pharma India Ltd and Mankind Pharma Partner to Accelerate Access to Asthma Medicine for Patients in India	Mar. 11	CI
India's Jubilant Pharmova posts quarterly profit	Feb. 02	RE
Mankind Pharma Posts Gains in Fiscal Q3 Consolidated Net Profit; Shares Rise 3%	Feb. 01	MT
India's Mankind Pharma beats Q3 profit estimates on strong demand	Jan. 31	RE
Mankind Pharma Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Jan. 31	CI
India's IPO momentum seen growing on prospects of political stability	Dec. 19	RE

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Mankind Pharma Limited

Equities

MANKIND

INE634S01028

Highlights

Filters